Patterns of PET-positive residual tissue at interim restaging and risk of treatment failure in advanced-stage Hodgkin’s lymphoma: an analysis of the randomized phase III HD18 trial by the German Hodgkin Study Group

被引：0
|
作者：
Justin Ferdinandus
Lutz van Heek
Katrin Roth
Markus Dietlein
Hans-Theodor Eich
Christian Baues
Peter Borchmann
Carsten Kobe
机构：
[1] Medical Faculty and University Hospital Cologne,Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne
[2] German Hodgkin Study Group (GHSG),Department of Nuclear Medicine
[3] University Hospital Cologne,Department of Radiation Oncology
[4] University Hospital Münster,Department of Radiotherapy and Cyberknife Center
[5] University Hospital Cologne,Department of Radiooncology
[6] Marienhospital Herne,undefined
[7] Ruhr University Bochum,undefined
来源：
European Journal of Nuclear Medicine and Molecular Imaging | 2024年 / 51卷
关键词：
PET; Hodgkin’s lymphoma; HD18 trial;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：490 / 495
页数：5
相关论文
共 50 条
  • [1] Patterns of PET-positive residual tissue at interim restaging and risk of treatment failure in advanced-stage Hodgkin's lymphoma: an analysis of the randomized phase III HD18 trial by the German Hodgkin Study Group
    Ferdinandus, Justin
    van Heek, Lutz
    Roth, Katrin
    Dietlein, Markus
    Eich, Hans-Theodor
    Baues, Christian
    Borchmann, Peter
    Kobe, Carsten
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 (02) : 490 - 495
  • [2] Patterns of PET positive residual tissue at early interim staging and risk of treatment failure in advanced-stage Hodgkin's Lymphoma: an analysis of the randomized phase III HD18 trial by the German Hodgkin Study Group
    Ferdinandus, J.
    van Heek, L.
    Roth, K. S.
    Dietlein, M.
    Eich, H.
    Baues, C.
    Borchmann, P.
    Kobe, C.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (SUPPL 1) : S47 - S47
  • [3] TREATMENT REDUCTION IN PATIENTS WITH ADVANCED-STAGE HODGKIN LYMPHOMA AND NEGATIVE INTERIM PET: FINAL RESULTS OF THE INTERNATIONAL, RANDOMIZED PHASE 3 TRIAL HD18 BY THE GERMAN HODGKIN STUDY GROUP
    Borchmann, P.
    Goergen, H.
    Kobe, C.
    Fuchs, M.
    Greil, R.
    Zijlstra, J. M.
    Huettmann, A.
    Markova, J.
    Meissner, J.
    Feuring-Buske, M.
    Bentz, M.
    Dierlamm, J.
    Kuehnhardt, D.
    Lohri, A.
    Novak, U.
    Eichenauer, D.
    Eich, H.
    Baues, C.
    Stein, H.
    Diehl, V.
    Kuhnert, G.
    Dietlein, M.
    Engert, A.
    HAEMATOLOGICA, 2017, 102 : 24 - +
  • [4] Treatment Reduction in Patients with Advanced-Stage Hodgkin Lymphoma and Negative Interim FDG-PET: Final Results of the International, Randomized, Phase 3 HD18 Trial by the German Hodgkin Study Group
    Kobe, C.
    Goergen, H.
    Fuchs, M.
    Eich, H. T.
    Baues, C.
    Diehl, V.
    Kuhnert, G.
    Drzezga, A.
    Dietlein, M.
    Engert, A.
    Borchmann, P.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 : S312 - S312
  • [5] Early Interim PET in Patients with Advanced-Stage Hodgkin's Lymphoma Treated within the Phase 3 GHSG HD18 Study
    Borchmann, Peter
    Goergen, Helen
    Kobe, Carsten
    Lohri, Andreas
    Greil, Richard
    Eichenauer, Dennis A.
    Zijlstra, Josee M.
    Markova, Jana
    Meissner, Julia
    Feuring-Buske, Michaela
    Huttmann, Andreas
    Dierlamm, Judith
    Sokler, Martin
    Krause, Stefan W.
    Eich, Hans
    Baues, Christian
    Kreissl, Stefanie
    Fuchs, Michael
    Dietlein, Markus
    Engert, Andreas
    BLOOD, 2017, 130
  • [6] Treatment reduction in patients with advanced-stage-Hodgkin-lymphoma and negative interim PET: final results of the international randomized phase 3 trial HD18 by the German Hodgkin Study Goup
    Kreissl, S.
    Goergen, H.
    Kobe, C.
    Fuchs, M.
    Greil, R.
    Huettmann, A.
    Meissner, J.
    Feuring-Buske, M.
    Bentz, M.
    Dierlamm, J.
    Kuehnhardt, D.
    Lohri, A.
    Novak, U.
    Eichenauer, D.
    Eich, H.
    Baues, C.
    Stein, H.
    Diehl, V.
    Kuhnert, G.
    Dietlein, M.
    Engert, A.
    Borchmann, P.
    ONCOLOGY RESEARCH AND TREATMENT, 2017, 40 : 201 - 201
  • [7] PET-guided treatment in patients with advanced-stage Hodgkin's lymphoma (HD18): final results of an open-label, international, randomised phase 3 trial by the German Hodgkin Study Group
    Borchmann, Peter
    Goergen, Helen
    Kobe, Carsten
    Lohri, Andreas
    Greil, Richard
    Eichenauer, Dennis A.
    Zijlstra, Josee M.
    Markova, Jana
    Meissner, Julia
    Feuring-Buske, Michaela
    Huttmann, Andreas
    Dierlamm, Judith
    Soekler, Martin
    Beck, Hans-Joachim
    Willenbacher, Wolfgang
    Ludwig, Wolf-Dieter
    Pabst, Thomas
    Topp, Max S.
    Hitz, Felicitas
    Bentz, Martin
    Keller, Ulrich Bernd
    Kuhnhardt, Dagmar
    Ostermann, Helmut
    Schmitz, Norbert
    Hertenstein, Bernd
    Aulitzky, Walter
    Maschmeyer, Georg
    Vieler, Tom
    Eich, Hans
    Baues, Christian
    Stein, Harald
    Fuchs, Michael
    Kuhnert, Georg
    Diehl, Volker
    Dietlein, Markus
    Engert, Andreas
    LANCET, 2017, 390 (10114): : 2790 - 2802
  • [8] Metabolic tumor volume after two cycles of chemotherapy in patients treated for advanced-stage Hodgkin Lymphoma: analysis of the German Hodgkin Study Group phase III HD18 and HD21 trials
    Kobe, C.
    Kaul, H.
    Schneider, G.
    Fuchs, M.
    Eich, H.
    Rosenbrock, J.
    Baues, C.
    Roth, K.
    Drzezga, A.
    van Heek, L.
    Dietlein, M.
    Borchmann, P.
    Ferdinandus, J.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 : S234 - S234
  • [9] PET-based evaluation of residual tissue in advanced-stage Hodgkin lymphoma: GHSG interim analysis of the HD15 trial
    Engert, A.
    Kobe, C.
    Haverkamp, H.
    Dietlein, M.
    Borchmann, P.
    Fuchs, M.
    Diehl, V.
    ANNALS OF ONCOLOGY, 2008, 19 : 120 - 120
  • [10] Relapse Analysis After Radiation Therapy of PET-Positive Residual Tumors of Patients With Advanced Stage Hodgkin Lymphoma Treated in the HD15 Trial of the German Hodgkin Study Group (GHSG)
    Eich, H. T.
    Kriz, J.
    Reinartz, G.
    Kobe, C.
    Kuhnert, G.
    Haverkamp, U.
    Haverkamp, H.
    Hegerfeld, K.
    Baues, C.
    Engert, A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013, 87 (02): : S5 - S6
12345